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The formation and activity of mammalian tissues entail finely regulated processes,
involving the concerted organization and interaction of multiple cell types. In recent
years the prospective isolation of distinct progenitor and stem cell populations has
become a powerful tool in the hands of developmental biologists and has rendered
the investigation of their intrinsic properties possible. In this protocol, we describe how
to purify progenitors with different lineage history and degree of differentiation from
embryonic and fetal skeletal muscle by fluorescence-activated cell sorting (FACS). The
approach takes advantage of a panel of murine strains expressing fluorescent reporter
genes specifically in the myogenic progenitors. We provide a detailed description of
the dissection procedures and of the enzymatic dissociation required to maximize the
yield of mononucleated cells for subsequent FACS-based purification. The procedure
takes∼6–7 h to complete and allows for the isolation and the subsequent molecular and
phenotypic characterization of developmental myogenic progenitors.
Keywords: embryonic myoblasts, fetal myoblats, FACS, reporter lines, myf5
INTRODUCTION
Development of the Protocol
Skeletal muscle development consists in the formation of contractile muscle fibers by
the progressive differentiation of distinct classes of progenitors that appear at subsequent
developmental stages. It is among the most studied developmental processes (Figure 1) (Stockdale,
1992; Tajbakhsh, 2005; Buckingham, 2006; Biressi et al., 2007a; Murphy and Kardon, 2011). The
first multinucleated fibers are formed approximately between E10.5 and E12.5 in the mouse, in a
phase, which is referred to as primary myogenesis. During this phase, embryonic progenitors of
somitic origin progressively commit to the myogenic fate and, upon migration to their appropriate
muscle anlagen, terminally differentiate by fusing with each other into fibers that are called primary
fibers. This lineage progression is a finely tuned process that depends on signals coming from the
adjacent developing tissues and neighboring cells present in the sites of muscle formation or co-
migrating with the myogenic progenitors (i.e. endothelial cells). During this process, a number of
muscle-characteristic genes are serially induced in the myogenic progenitors as they progress from
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FIGURE 1 | Intrinsically different myogenic lineages govern embryonic and
fetal phases of muscle fiber formation. Schematic representation of the major
phases of myogenesis that are occurring during skeletal muscle development.
Embryonic progenitors that are responsible for primary myogenesis are
predominating between E10 and E13, whereas fetal progenitors that are
responsible for the secondary myogenesis are predominating between E14
and E18. Post-natal progenitors/stem cells are responsible for muscle growth
after birth. The developmental time corresponding to the different phases of
myogenesis in the mouse is indicated on the x-axis. Embryonic days are
counted, considering E0.5 the morning of the vaginal plug. Myotomal cells
giving rise to the early embryonic myotome is omitted from this scheme.
their initial specification to terminal differentiation. These genes
include themembers of the Pax family of specification genes Pax3
and Pax7 and muscle determination genes, such as the myogenic
regulatory factors (MRFs) Myf5 or MyoD (Figure 2A). Only a
fraction of myogenic progenitors terminally differentiates during
primary myogenesis. The remaining are kept in a committed
but undifferentiated state (likely depending on Pax7 expression)
until subsequent fetal and post-natal phases of myogenesis. The
fetal phase of muscle formation usually referred to as secondary
myogenesis, peaks between E14.5 and E17.5 in the mouse.
This phase depends on the fusion of MRF+ve fetal myoblasts,
in a process that is similar to that described for embryonic
progenitors during primary myogenesis, although some of the
fetal cells also fuse with primary embryonic myofibers. Despite
some general similarities, studies from different laboratories,
including our own, identified specific properties of embryonic
and fetal myogenic progenitors, which characterize them as
intrinsically different classes of cells terminally differentiating
in muscle fibers with distinct biochemical and metabolic
characteristics (Stockdale, 1992; Biressi et al., 2007a; Murphy
and Kardon, 2011). In general, fibers formed during mammalian
primary myogenesis (and myotubes formed from the fusion of
embryonic progenitors in vitro) are predominantly programmed
for a slow phenotype, whereas those formed during secondary
myogenesis (and myotubes formed by fetal myoblasts in vitro)
acquire a fast phenotype (Zhang et al., 1998; Wigmore and
Evans, 2002). Although the activity of the nerves plays a well-
documented role in fiber type specification, the phenotypic
diversification of developmental myogenic progenitors during
differentiation in vitro is occurring independently on innervation
(Biressi et al., 2007b). This body of evidence highlights a distinct,
intrinsically codified physiological function for muscle fibers
formed at different developmental stages.
Myogenic progenitors represent only a minority of the
cells that comprise the embryonic and fetal mesoderm. The
heterogeneity of the cell types coexisting in the growing muscle,
and the complexity of their interrelationships severely limit the
type of questions about developmental mechanisms that can
be reliably answered in the intact organism or in cells isolated
from total mesoderm. Signals coming from the surrounding non-
myogenic cells dramatically influence the characteristics and fate
of muscle progenitor cells, complicating the interpretation of
many previous observations.
Here we describe a protocol that allows the isolation of pure
populations of myogenic progenitors at different developmental
stages. We used this method to prove that embryonic and fetal
myoblast are intrinsically different progenitors (Biressi et al.,
2007b, 2008; Messina et al., 2010; Taglietti et al., 2016). We
also used this protocol to separate embryonic progenitors with
different degree of differentiation (Biressi et al., 2008; Boutet
et al., 2010), and to define the developmental origin of the adult
muscle stem cells (Biressi et al., 2013). The use of this procedure
should further expand the opportunities to (1) investigate
common and unique properties of specific subpopulations,
(2) allow in vitro studies of molecules that regulate muscle
cell growth and differentiation, (3) perform molecular and
functional studies in the absence of confounding contaminants,
(4) characterize cells at different stages of myogenic progression
and differentiation, (5) investigate the intrinsic properties and
phenotypic plasticity of muscle fiber subtypes in the absence
of innervation, (6) isolate and analyze mutant myoblasts from
genetically modified animals, and (7) use these cells in cell
transplantation studies in animal models of human disease. The
possibility of purifying specific cell subpopulations and analyzing
them under controlled conditions offers the opportunity to
investigate their intrinsic properties. Furthermore, the response
of these cells to defined stimuli can conveniently be studied
without the confounding presence of other cell types. With the
advent of next-generation sequencing and single cell analysis,
it becomes possible to dissect the molecular determinants
governing cellular dynamics. Importantly, these techniques rely
on the possibility of identifying and isolating specific cell
populations. The definition of reliable procedures of cellular
purification, such as those described in this protocol, offers the
possibility to apply these investigative approaches to skeletal
muscle development and differentiation.
Comparison With Other Flow Cytometry
Methods
Although several strategies have been proposed to isolate
myogenic progenitors from adult muscles by flow cytometry
(Gromova et al., 2015; Liu et al., 2015) until now only a few
approaches for perspective isolation of myogenic cells from
developing muscles have been reported. One method employs an
enrichment step through Percoll density centrifugation followed
by a subsequent selection using 90◦ light scattering (Yablonka-
Reuveni, 1988). This method is reportedly effective in purifying
myogenic progenitors from 10-day-old chicken embryos, but no
evidence for its efficacy at later stages or in other organisms
is documented. FACS-based approaches relying on antibodies
recognizing specific markers have been conversely reported to
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FIGURE 2 | Discrimination between progenitors with different degree of differentiation. (A) Schematic representation showing the expression of the reporter GFP in
Pax3GFP and Myf5GFP−P mice during the myogenic lineage progression at the embryonic stage. Different steps of the lineage progression leading to terminal
differentiation are indicated on the x-axis. (B) Representation of the numerical proportion and position of MRFs−ve and MRFs+ve progenitors expressing GFP in limbs
of Pax3GFP and Myf5GFP−P at E11.5. Note that only in the Pax3GFP embryos GFP is expressed in migrating MRFs−ve progenitors.
purify fetal myogenic progenitors from both human and mouse
muscles. Human fetal myoblasts are identified as melanoma
cell adhesion molecule (MCAM)+ve cells (Lapan and Gussoni,
2012), but if the same marker is effective in purifying myogenic
progenitors from different species and stages is unknown. In the
case of mouse fetal progenitors, the use of different combinations
of markers that include integrin α7 (Itga7) have been proposed
(Castiglioni et al., 2014; Tierney et al., 2016). Nevertheless,
the preferential expression of Itga7 in fetal progenitors in
comparison to their embryonic counterpart, suggests that this
approach may not be extended to embryonic developmental
stages (George-Weinstein et al., 1993; Biressi et al., 2007b). To
date, the approach we describe here is the only one that has been
proven to effectively purify cells from both embryonic and fetal
stages.
The reporter-based approach described here is also the only
one that allows for the purification of myogenic progenitors at
different steps of their lineage progression. Taking advantage of a
set of mutant mice expressing a reporter under the control of the
regulatory sequences of genes explicitly expressed during specific
phases of the maturation of developmental progenitors (Table 1),
it is possible to purify individual myogenic progenitors that,
although coexist in the same environment, present differences in
terms of commitment and differentiation.
Experimental Design
The isolation protocol consists of two main parts: (i) the isolation
and identification of the fluorescent progeny (Steps 1–14) and (ii)
the dissection of embryos or fetuses, followed by the enzymatic
dissociation of cells and FACS isolation of progenitors (Steps
15–32). We also describe how to freeze the cells for different
types of analysis and how to culture them in vitro (Step 33). The
execution of this protocol generally requires the involvement of
an animal husbandry and a cytometry facility. Operators need
minimal manual skills, basic knowledge of mouse embryology
and anatomy, tissue culture and cytofluorimetry.
Obtaining the Fluorescent Embryos or Fetuses
The protocol we describe here is based upon mutant mice that
express a reporter gene in developmental myogenic progenitors.
Over the years, we gained experience with five mouse strains
and tested their suitability to isolate progenitors at specific
developmental stages and from specific anatomical districts
(Table 1). The mice we use rely on the regulatory sequences of
Pax specification andMyf5 determination genes for the induction
of the reporter gene (eGFP or DsRed.T3). These strains allow
the purification of myogenic progenitors with a different stage
of commitment or differentiation. Pax3 is expressed in muscle
progenitor cells that subsequently become myogenic and form
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TABLE 1 | Summary of the mouse lines described in this protocol.
Genotype Genetic manipulation Tested Comments References
Myf5GFP−P/+ Genetic knock-in: a sequence encoding
eGFP replaces part of exon 1 of Myf5.
E/F Myf5 is the first of the determination MRFs to be expressed in
myogenic progenitors throughout development.
Kassar-Duchossoy
et al., 2004
Pax3GFP/+ Genetic knock-in: a sequence encoding
eGFP replaces exon 1 of Pax3.
E/F Expressed in embryonic progenitors before myogenic
determination. GFP expression persists in myogenic progenitors
at fetal stages (Relaix et al., 2005).
Relaix et al., 2005
Myf5-NNCre/wt;
Z/REDmut/wt
Genetic mutant: a sequence encoding for
Cre recombinase is inserted in the 3’UTR
of Myf5. The MC1-Neo cassette was
removed.
E (limbs) Relies on a Cre recombinase-inducible reporter such as the
Z/RED transgenic line (Vintersten et al., 2004). Possible ectopic
Cre-mediated reporter expression (Figures 4A,B).
Haldar et al., 2008
MCremut/wt;
Z/REDmut/wt
Transgenic expression of
Cre-recombinase under the control of
hypaxial muscle element of Pax3.
E (limbs) Muscle specific, expressed only in hypaxial embryonic
precursors. Variable efficiency (Schienda et al., 2006). Relies on a
Cre recombinase-inducible reporter (Vintersten et al., 2004).
Potential ectopic Cre-mediated reporter expression.
Brown et al., 2005
Pax7-ICNCre/wt;
Z/REDmut/wt
Genetic mutant: a sequence encoding for
Cre recombinase is inserted in the 3’UTR
of Pax7.
F (limbs) Pax7 is expressed in undifferentiated myogenic progenitors at
embryonic and fetal stages in the trunk and at fetal stages in the
limbs. Relies on a Cre recombinase-inducible reporter (Vintersten
et al., 2004). Possible rare ectopic Cre-mediated reporter
expression (Figure 4B).
Keller et al., 2004
E, embryonic stage; F, fetal stage.
skeletal muscle. The commitment to the myogenic program is
dependent on the expression of a determination gene belonging
to the MRF family, such as Myf5 (Figure 2A). Therefore pure
population of embryonic (and fetal) committed myoblasts can be
isolated from Myf5GFP−P mice, whereas a pool of uncommitted
(Myf5−ve) and committed progenitors can be isolated from
Pax3GFP mice (Figure 2B; Biressi et al., 2008). Pax3GFP mice
are suitable to enrich for undifferentiated myogenic progenitors
also at fetal stages. Indeed due to its stability, eGFP is
reportedly expressed in uncommitted fetal progenitors even
though the Pax3 locus is downregulated (Relaix et al., 2005).
We also differentially enriched for embryonic committed and
uncommitted progenitors, by employing alternative mouse
strains expressing Cre recombinase under the control of the
regulatory regions of Pax3 andMyf5 (Table 1 and Supplementary
Figure 1A; Boutet et al., 2010). Pax7-ICNCre/wt mice expressing
Cre from the Pax7 locus can conversely be effectively used
to purify myogenic progenitors from fetuses (Table 1 and
Supplementary Figure 1A). These approaches depend on the
conditional expression of a reporter under the control of a
constitutive promoter upon the induction of Cre recombinase.
We regularly used the Z/RED construct for expressing the
reporterDsRed.T3 from a transgene comprising a CMV enhancer
and chicken β-actin promoter upon Cre-dependent activation
(Vintersten et al., 2004), but alternative reporter lines such
as those relying on the ROSA26 locus provide an alternative
(Soriano, 1999; Abe and Fujimori, 2013). Noteworthy, the
described strategies based on the Cre-LoxP system and those
dependent on the direct expression of the reporters from the
locus of the myogenic genes display some intrinsic differences
that should be taken into account before extrapolating and
comparing conclusions from data obtained with one or the
other approach. Indeed, upon Cre-mediated recombination,
the expression of the reporter will become independent from the
regulatory sequence controlling Cre expression, and due to its
dependency on a constitutive promoter will remain active also
when mononucleated progenitors fuse into the fibers. Moreover,
the nature of strains expressing Cre and the time required for
Cre to be expressed and effectively activate the expression of
the reporter gene may potentially determine a delay in the
expression of the reporter compared to the expression of the
endogenous marker (Supplementary Figure 1B). Beside the five
mouse strains that we describe here, several other lines have been
reported, which express reporter genes or Cre recombinase under
the control of the regulatory sequences of muscle-characteristic
genes (Tallquist et al., 2000; Chen et al., 2005; Engleka et al.,
2005; Haldar et al., 2007; Bosnakovski et al., 2008; Sambasivan
et al., 2009; Wood et al., 2013; Southard et al., 2014). Some of
them have the advantage of being commercially available from
Jackson labs. Although they require validation, they are likely to
be suitable for developmental myogenic progenitor purification
with this protocol.
The involvement of distinct classes of progenitors in
successive phases of myogenesis, calls for accurate identification
of the developmental stages. Some instructions to set up timed
pregnant females are provided for the investigators that are
approaching developmental studies for the first time, along with
some advice on the breeding strategies we use to facilitate the
successful completion of the protocol. Along the same line, a
detailed description of the steps required to rapidly collect viable
embryos and fetuses is also provided. Moreover, we detail in this
protocol the modality of selection that is applied to immediately
identify embryos and fetuses that express the reporter in the
myogenic compartment. Although genotyping protocols that
require a relatively short time are available (and may still be
performed as a verification step), the possibility to immediately
identify embryos and fetuses that are suitable for progenitor
isolation is crucial to ensure the viability of the purified cells.
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In this protocol, we also discuss some limitations of the mouse
strains we use and offer some tips to overcome them.
Dissociation and FACS Isolation
Myogenic progenitors represent only a small fraction of the cells
present in the embryonic and fetal mesoderm. To increase the
yield of myogenic progenitors, and reduce the time required
for their isolation, it is imperative to collect the portions of
the embryos and fetuses, which are particularly enriched for
myogenic progenitors, eliminating those devoid of myogenic
progenitors. The body organization dramatically changes as
the developing organism transits from the embryonic to the
fetal stage. We, therefore, describe two alternative approaches
respectively applicable to E10.5–E12.5 embryos (Step 14A) and to
E14.5–E17.5 fetuses (Step 14B). This phase of dissection is crucial
also to eliminate the portion of the embryos/fetuses in which
the reporters are expressed outside the myogenic compartment.
Indeed, the Pax3, Pax7, and Myf5 locus are reportedly active
also in the developing nervous system (including neural tube
and dorsal root ganglia; Tajbakhsh et al., 1994; Tajbakhsh and
Buckingham, 1995; Buckingham and Relaix, 2015). Moreover,
a number of observations suggest that cells with a history of
Myf5 expression contribute to fetal rib chondrogenesis and
brown adipose tissue formation. A contribution of cells of the
Myf5-lineage to the pool of dermal precursors in the embryonic
epaxial domain has also been proposed (Haldar et al., 2008).
Therefore, although we have regularly used the Myf5-NNCre
line to effectively purify myogenic progenitors from the limbs
at embryonic stages (Boutet et al., 2010; Biressi et al., 2013),
we recommend the assessment of the expression of myogenic
markers before extending the protocol to different stages and
portions of the embryos. Similarly, we used the Pax7-ICNCre
line to successfully purify myogenic progenitors from fetal limbs
(Biressi et al., 2013), but the report of an active Pax7 locus in
progenitors contributing to dermal and brown adipose lineages
at embryonic stage put in question the possibility to use the
same approach in different conditions (Lepper and Fan, 2010).
For each genotype described in this protocol, the validated
developmental time and body domains are indicated in Table 1.
Embryonic and fetal tissues are composed of multiple types
of cells that are continuously interacting with each other
and with the extracellular matrix. As development proceeds,
multinucleated fibers appear in the muscle anlagen. An efficient
release of mononucleated cells is crucial to maximize the yield
of myogenic progenitors. In this protocol, dissected embryos
and fetuses are subjected to cycles of physical and enzymatic
dissociation, under buffered conditions. A filtration step will
ensure the removal of fiber debris.
The cellular suspension is immediately processed by FACS.
When the dissection and isolation phases have been optimized,
and the appropriate controls used, populations of cells expressing
or not expressing the reporter can be readily identified (Figure 7
and Supplementary Figure 4). Defining appropriate SSC and FSC
gates is crucial to eliminate dead cells and debris, in particular at
the fetal stage when more mature muscle fibers are present. With
experience, the great majority of isolated cells are viable, but the
addition of live-dead dyes, such as 7-AAD (7-amino-actinomycin
D) or propidium iodide may help in identifying them and verify
that the procedure has been performed correctly (Biressi et al.,
2007b).
Characterization of Purified Myogenic Progenitors
Myogenic progenitors isolated with this protocol can be
processed for molecular investigations, such as the quantification
of transcript or protein levels, which require RNA and protein
extraction, respectively. Furthermore, cells can be cultured in
vitro to evaluate intrinsic parameters such as proliferation,
motility, differentiation, and fusion into multinucleated syncytia
with different morphological, biochemical and functional
properties (Biressi et al., 2007b; Boutet et al., 2010). For
investigators learning this protocol or adapting it to new
conditions and developmental stages, we recommend to verify
the purity of the sorted populations by reanalyzing a small
number (>1,000) of cells at the cytofluorimeter (Supplementary
Figure 5) or by plating them and stain them with antibodies
recognizing the reporter used for isolation or myogenic markers
(Figure 8).
MATERIALS AND EQUIPMENT
Reagents
• WT and mutant mice expressing a reporter in myogenic
progenitors (Table 1). We have used WT CD1 or C57BL/6
mice from the Jackson Laboratory or Charles River.
CAUTION Experiments using murine strains must be
approved by the Institute Animal Welfare Body and by the
local authorities, and must conform to EU law of the Member
countries (2010/63/UE) or relevant national and institutional
regulations and laws.
• 1x phosphate buffer saline (PBS) pH 7.4 (ThermoFisher
Scientific 10010031)
• Ethanol 70% (vol/vol)
• DMEM (High Glucose) (ThermoFisher Scientific 10938025)
• Penicillin/streptomycin mixtures (P/S) (100X, Omega
Scientific PS-20)
• HEPES 1M (ThermoFisher Scientific 15630080)
• L-Glutamine 200mM (ThermoFisher Scientific 25030081)
• 1x Ca2+-free Hanks’ balanced salt solution (HBSS)
(ThermoFisher Scientific 14170070)
• Bovine serum albumin (BSA) (Sigma A1933)
• Glucose (Sigma G7021)
• Magnesium sulfate (MgSO4) (Sigma M2643)
• Sodium hydroxide (NaOH) 1N (Sigma S2770)
• EDTA disodium salt (Sigma E6635)
• Ammonium chloride (NH4Cl) (Sigma A9434)
• Potassium bicarbonate (KHCO3) (Sigma 60339)
• EDTA tetrasodium salt hydrate (Sigma E5391)
• Fetal bovine serum (FBS) (ThermoFisher Scientific 10270106)
• Collagenase Type V (Sigma C9263)
• Dispase (ThermoFisher Scientific 17105041)
• DNAse I (Worthington LS002139)
• Parafilm
• Horse serum (ThermoFisher Scientific 16050122)
• Calf skin collagen (Sigma C8919)
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FIGURE 3 | Identification of embryos and fetuses suitable for progenitor purification. (A) Green fluorescence in the myotome/dermomyotome (dm), fore (FL), and hind
(HL) limbs of an E11.5 Myf5GFP−P/+ embryo. (B) Limbs of E16.5 Pax7-ICNCre/wt; Z/REDmut/wt and WT fetuses (dashed line) were squeezed between two
microscope slides, and red fluorescence was evaluated. Note that muscle fibers, which are clearly apparent in the bright field (lower), are fluorescent only in
Pax7-ICNCre/wt; Z/REDmut/wt fetuses (upper).
FIGURE 4 | Occasional ectopic Cre-mediated reporter expression in compound mutant. (A) Representative pictures of the trunk of Myf5-NNCre; Z/REDmut/wt E11.5
embryos presenting ubiquitous (upper) or muscle-specific (lower) fluorescence. In the latter case, DsRed.T3+ve myotomes/dermomyotomes are easily identified at the
microscope. (B) Quantification of the progeny characterized by muscle-specific or ubiquitous reporter gene expression after crossing double mutant males presenting
both “inducer” (expression of Cre recombinase) and “reporter” (Cre-mediated permanent expression a reporter gene) features with WT females. Myf5-NNCre and
Pax7-ICNCre inducer lines are compared to each other.
• ECM gel from Engelbreth-Holm-Swarm murine sarcoma
(Sigma E1270)
• Ultrapure distilled water (ThermoFisher Scientific 10977023)
• 16% Formaldehyde (w/v), Methanol-free (ThermoFisher
Scientific 28906)
• CAUTION Hazardous in case of eye contact and on ingestion
• Anti-Pax7 (Developmental Studies Hybridoma Bank
AB_528428)
• Anti-MyoD (Dako M3512)
• Anti-Myogenin (BD Pharmingen 556358)
• Anti-Desmin (Sigma SAB5600054)
• DAPI (diamidino-2-phenylindole) (Sigma 32670)
• Ice
• Liquid nitrogen.
Equipment
• 10-cm Petri dishes
• 37◦C shaking water bath (Grant LSB18 or equivalent)
• CO2 chamber
• Dissection scissors
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FIGURE 5 | Progressive dissection of an E11.5 embryo. (A) The head of the embryo is removed. (B) After placing the embryo on one side, the internal organs laying
between the upper (FL) and lower (HL) limbs are removed by using needles. (C) Photo of an E11.5 embryo after removal of the internal organs presenting intact FL,
HL, and lateral body wall. (D) After placing the embryo with the ventral portion facing down, needles are used to cut the embryo cranio-caudally (dashed line) lateral to
the dorsal root ganglia (DRG) and neural tube (NT) and medial to the somites (S). (E) The operation described in (D) is repeated on both sides of the NT. (F) The
embryo (divided into a right and left portion) is dissected free from the NT. (G) The isolated portions the embryos are placed in a 15ml tube containing digestion
solution. (H) Through vigorous shacking embryonic tissues are disaggregated in small (<1 mm3) pieces.
• Dumont forceps with curved tips
• Dumont forceps with straight tips
• Inverted fluorescent microscope
• Sterile hood for cell culture
• Stereomicroscope
• 6-well culture dish
• Microscope glass slides (ThermoScientific J1800AMNZ or
equivalent)
• Permanent Marker
• Insulin syringes with G27 needles
• Sterile 500-ml beaker
• Magnetic stirrer
• PH-meter
• Stericup Filter Units with 0.22-µm filters (Millipore
SCGVU02RE)
• Steriflip Vacuum Driven Sterile Filters with 0.22-µm filters
(Millipore SCGP00525)
• 15-ml conical tube (Falcon 352096 or equivalent)
• 50-ml conical tubes (Falcon 352070 or equivalent)
• Weights for water bath
• Racks for 15-ml and 50-ml conical tubes
• Sterile 5-ml serological pipets and a pipet
controller
• Refrigerated microcentrifuge (Sorvall Legend Micro 21R or
equivalent)
• Refrigerated centrifuge with swing rotor (Eppendorf 5810R or
equivalent)
• Falcon 5-ml round bottom tubes with strainer cap (Fisher
Scientific 08-771-23 or equivalent)
• Falcon 5-ml round bottom tubes (Fisher Scientific 14-959-2A
or equivalent)
• Cell counting chamber (Hemocytometer)
• BD FACSAria II or Vantage SE cell sorter (BD Biosciences)
• 1,5-ml conical bottom microcentrifuge tube
• BioCoatTM Poly-D-Lysine 8 Well Culture Slides (Corning
354632)
• 96-well culture dish
• Standard CO2 cell culture incubator
• 2–20, 20–200, 100–1,000 µl Gilson pipets and matching
filtered sterile tips
• Examination gloves
• Ice bucket.
Reagents Setup
Supplemented DMEM medium DMEM (High Glucose) is
supplemented with sterile P/S (1x), glutamine (2mM), HEPES
(10mM). It is recommended that renew glutamine every couple
of weeks. Store the medium at 4◦C until ready to use.
Dissociation Buffer This solution is consisting of HBSS
containing 0.3% (weight/vol) BSA, 15mM HEPES, 1.5mM
MgSO4 and 15mM glucose. The pH of the solution is set to 7.4
with NaOH by using a pH-meter. The sterility of the solution
is obtained by filtering through 0.22-µm Stericup filters. This
solution may be stored at 4◦C for a month.
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FIGURE 6 | Progressive dissection of an E15.5 fetus. (A) The head of the fetus is removed. (B) After placing the fetus with the ventral portion facing up, forceps are
used to cut the thorax and abdomen and expose the internal organs. (C) The fetus shows an empty body cavity after removal of the heart, lungs, liver, gastrointestinal
tract and other internal organs. (D) E15.5 fetus with the dorsal portion facing up, from which limb extremities have been dissected out. The skin (Sk) is translucent and
clearly visible. (E) A skinned fetus presenting large inter-scapular fat pads (FP, dashed line). (F) A skinned fetus from which inter-scapular fat pads have been removed.
(G) Position of the tubes (arrow) in the water bath during enzymatic digestion. Additional abbreviations in the scheme: Li, Liver; FL, fore limes; HL, hind limbs; SC,
spinal cord; GI, gastrointestinal tract.
Stock Collagenase/Dispase Solution Dissolve Collagenase V
and Dispase powder in 1X HBSS so that the final concentrations
are 3.75 mg/ml and 12 U/ml, respectively. Sterilize with 0.22-µm
Steriflip filters and store as 1-ml aliquots at −20◦C. Thaw before
use.
Stock DNAse I Solution Reconstitute the lyophilized powder
in sterile water at the final concentration of 10 mg/ml. Store as
500-µl aliquots at−20◦C. Thaw before use.
Digestion Solution This reagent should be prepared freshly
by dissolving Stock Collagenase/Dispase Solution (3%, vol/vol)
and Stock DNAse I Solution (0.1% vol/vol) in Dissociation Buffer,
and kept on ice until needed. Prepare 8 or 16ml every 6 embryos
or fetuses, respectively.
Erythrocyte Lysis Solution Dissolve in 1x PBS NH4Cl
(0.15M), KHCO3 (10mM), EDTA tetrasodium salt hydrate
(0.1mM) and sterilize with 0.22-µm Steriflip filters. This
solution may be stored at room temperature for several
weeks.
Sorting Solution Dilute supplemented DMEM medium with
20% (vol/vol) FBS in a beaker. On a magnetic stirrer dissolve
EDTA disodium salt (2mM). Sterilize the resulting solution with
0.22-µm Stericup filters. Store the medium at 4◦C until ready to
use.
Collecting Medium Dilute supplemented DMEM medium
with 50% (vol/vol) FBS. Store the medium at 4◦C until ready to
use.
Plating Medium 20% (vol/vol) horse serum is added to
supplemented DMEM medium. Store the medium at 4◦C until
ready to use.
Collagen coating Solution This solution is prepared by
diluting the commercial solution (1 mg/ml) 10-fold with sterile
water.
ECM coating Solution This solution is prepared by diluting
ECM gel 1:100 in ice-cold non-supplemented DMEM. Prepare
freshly before use. It is important to keep the reagents constantly
at 4◦C as ECM gel solidifies at a higher temperature.
Equipment Setup
BD FACSAria cell sorter The 488 nm laser is required for the
detection of the fluorochromes recommended in this protocol.
We use a BD FACSAria II sorter, but the scheme we describe
here should be applicable also to other models. Calibrations are
verified with tracking beads, and the presence of a stable breakoff
is ensured according to the manufacturer’s guidelines.
Collagen-coated plastic cell culture dishes Cover cell culture
plastic wells with collagen coating solution. Allow the collagen to
bind for several hours at room temperature or overnight at 4◦C.
Carefully aspirate excess fluid and allow it to dry completely in a
cell culture hood. Overnight exposure to UV light in a cell culture
hood may ensure sterility. Collagen-coated wells may be sealed
with Parafilm and stored for a few weeks at room temperature.
Frontiers in Physiology | www.frontiersin.org 8 April 2018 | Volume 9 | Article 352
Kheir et al. Isolation of Developmental Muscle Progenitors
FIGURE 7 | Representative FACS profiles of fetal myogenic progenitors. (A) Profile of cells obtained after digestion of E15.5 WT fetuses (GFP−ve controls). (B) Profile
of myogenic progenitors obtained after digestion of E15.5 Myf5GFP−P fetuses, as described in this protocol. Cells in P3 gate are myogenic progenitors. The
population hierarchy is shown under the plots. Abbreviations: SSC, Side scatter; FSC-A, Forward scatter-Area; FSC-H, Forward scatter-Height.
ECM-coated glass chamber slides BioCoat
TM
Poly-D-Lysine
8 Well Culture Slides should be coated with freshly prepared
ECM coating solution. Add a sufficient volume of freshly
prepared ECM coating solution to cover the bottom of the vessels.
Incubate for a minimum of 6 h at 4◦C. The culture slides can then
be stored at 4◦C for up to a week with the coating solution on
them. Aspirate the coating solution and seed cells immediately.
PROCEDURE
Setting Up Timed Pregnant Mice-TIMING
5 min
1. Add 1-2 females to each stud male cage. As females will be
sacrificed during the following steps of the procedure, we
usually cross mutant males with commercially available WT
females. This strategy has some limitations that are discussed
in Step 14 of this protocol.
2. Check the presence of vaginal plugs the subsequent morning.
We consider the morning a plug is observed as gestational day
E0.5.
CRITICAL STEP The presence of a vaginal plug does not
necessarily guarantee pregnancy, but only indicate that mating
occurred. In our experience, the likelihood of pregnancy
after mating depends on the mouse strain. When the
experimental design does not require the use of mice of a
specific background, we use the outbred CD1 strain that has
higher fertility, compared to the classically used C57BL/6
strain.
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FIGURE 8 | Confirmation of the myogenicity of isolated progenitors. (A) Immediately after FACS isolation, cells from Myf5GFP−P embryos (E11.5) or fetuses (E15.5)
were plated on collagen-coated wells. Cells were fixed with 4% (wt/vol) paraformaldehyde 12 h after plating and were stained with antibodies recognizing desmin
according to standard protocols. (B) Cells FACS-purified from the limbs of Pax7-ICNCre/wt; Z/REDmut/wt fetuses (E15.5) were plated on ECM-coated glass chamber
slides, fixed as in (A) and stained with a cocktail of antibodies against Pax7, MyoD, and Myogenin (Mgn). A high magnification picture of individual cells is shown in the
insets. DAPI was used to stain nuclei.
Collection of Embryos and
Fetuses-TIMING 20min per Pregnant
Female
3. Prepare 10-cm Petri dishes with 10ml of sterile PBS (four
dishes per pregnant female). PBS should be pre-warmed at
37◦C and dishes containing PBS should maintained at 37◦C
until their use.
4. Euthanize the pregnant female in a CO2 chamber and
subsequently perform cervical dislocation to ensure death.
CAUTION The method used to kill mice must be approved
by your institutional guidelines and national laws.
5. Spray the skin of the mouse with 70% (vol/vol) ethanol, and
place it in the dissection area.
6. Make a U-shaped incision of the abdomen (skin and muscle
layers) with scissors (Supplementary Figure 2A).
7. Lift the abdominal wall up with forceps to expose the uterus
(Supplementary Figure 2B).
8. Grasp the uterine horns close to their convergence at the
cervix with forceps, and cut them free with fine scissors
(Supplementary Figure 2C).
9. Carefully pull the complete uterus out of the
abdominal cavity with fine forceps and place it in
a dish containing 10ml of PBS (Supplementary
Figure 2D).
10. After a couple of minutes, gently transfer the uterus in a
clean dish containing PBS to wash the surrounding blood
away.
11. With fine scissors and forceps open the uterus to expose the
embryos/fetuses enclosed in their yolk sac (Supplementary
Figures 2E,F).
CRITICAL STEP Be careful not to squeeze or cut the
embryos.
12. With fine sterile forceps remove each embryo/fetus with
yolk sac from the placenta and gently transfer it to a clean
dish containing PBS to eliminate the surrounding blood
(Supplementary Figures 2G,H).
13. Gently remove the yolk sac (Supplementary
Figure 2I) and the amniotic sac (Supplementary
Figure 2J), and transfer the embryos/fetuses in a dish
containing PBS.
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TABLE 2 | Troubleshooting table.
Step Problem Possible reason Solution
2 Unsuccessful mating
Difficult identification of the
vaginal plug
Age of the mice or housing conditions are
not optimal
Plugs of certain strains, such as C57Bl/6
dissolve rapidly
Tips to increase the probability of a successful mating are described in the
Jackson Laboratory’s website at https://www.jax.org/news-and-insights/jax-
blog/2014/september/six-steps-for-setting-up-timed-pregnant-mice
Check the plugs early in the morning
Use alternative strains such as CD1 or FVB mice when possible
14A Difficult identification of the
fluorescent embryos
Insufficient microscope sensitivity. Focusing in the bright-field on the myogenic compartment (i.e. limb buds or
dermomyotomes) of the embryos before analyzing the fluorescent signal may
facilitate the identification
Direct comparison with non-fluorescent embryos may also be helpful
Use for embryos the same approach described for fetuses (Step 14B)
14B High auto-fluorescence Sample is drying out. Skin incompletely
removed.
Carefully eliminate skin and bones
Process one sample at the time
15 Poor cell yield Not all myogenic portions are collected Carefully dissect the tissues by using a stereomicroscope
Low purity
Yeast or bacterial
contamination
Incomplete removal of contaminating
tissues
Unsterile environment or tools
Carefully dissect the tissues by using a stereomicroscope
Check at the fluorescence microscope for residual contaminating tissues
Dissect by using sterile tools and examination gloves in a sterile hood
18 Yeast or bacterial
contamination
Luck of attention to sterile handling
techniques
Use standard sterile techniques and open the tubes in a sterile hood
19 Poor cell yield Incompletely digested tissues are aspirated
with the fully disaggregated cells
Do not attempt to aspirate all of the supernatant
Aspirate slowly from the surface of the solution
Use a 100–1,000 µl pipette to aspirate
22 Poor cell yield and/or purity Cells are not fully dissociated Shake vigorously 2–3 times at Step 20
Gently disaggregating with a 5ml pipette could be an alternative
24 Poor cell yield The cell suspension is entrapped in the
strainer
Change the strainer if it is clogged
Carefully recover all liquid from both sides of the strainer
30 Poor cell yield Presence of dead or apoptotic cells Optimize the isolation procedure
Draw stringent FSC and SSC gates
Use live-death dyes or Annexin V conjugates to identify dying or apoptotic
cells, respectively
31 Poor purity Fluorescent cells are not well separated
from the background
Optimize the isolation procedure
Draw stringent gates to exclude contaminants
32 Sorter clogs/Poor purity Excessive debris is present
Cells have aggregated
Optimize the procedure. Different developmental stages may require for slight
modifications in the protocol, in particular at Steps 17–22.
Proceed with the sorting immediately after passing the sample trough the
strainer
Gently vortex or pipette up and down the cell suspension before sorting
Filter again through a strainer if necessary
Frequently agitate or vortex the sample during sorting
33 Loss of cells Cells are aspirated Remove the supernatant slowly from the side of the tube oriented toward the
center of the centrifuge to not disturb the pellet
Yeast or bacterial
contamination
Unsterile sorting or culturing conditions Periodically decontaminate the cell sorter
Before sorting the fluidic system should be rinsed with ethanol 70% (vol/vol)
Use only sterile cell culture reagents
Check for possible contaminations in the filters of the incubator and hood
Identification of Fluorescent Progeny
-TIMING 20min per Pregnant Female
14. When we are setting up the breeding (Step1), we usually
use heterozygous mutant stud males. This is an obvious
requirement for strains that may be lethal in homozygousity,
such as the Pax3GFP strain, which is devoid of Pax3
expression. The implication of this approach is the presence
of both “fluorescence positive”(mutants expressing the
fluorescent reporter required for the identification of the
myogenic progenitors) and “fluorescence negative” (used
as negative controls in Step 28) progeny. To finalize
the protocol in a timely manner and to optimize the
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yield of myogenic progenitors, a key point is to identify
the fluorescent embryos before the dissection and the
enzymatic digestion (Steps 15-22). The modality of selection
of the fluorescent progeny is different according to the
developmental stage: embryonic stage (from E10.5 to
E12.5) (option A) or fetal stage (from E14.5 to E17.5)
(option B). Both options imply the identification of
the progeny expressing the fluorescent reporter in the
myogenic compartment by microscopic investigation. These
approaches are:
(A) Selection of Fluorescent Embryos
(i) Prepare a 10-cm Petri dish with 10ml of sterile PBS. PBS
should be pre-warmed at 37◦C.
(ii) Place the dish containing embryos under an inverted
fluorescence microscope and observe with the filter
appropriate for the employed reporter (Figure 3A).
CRITICAL STEP The selection of the fluorescent embryos
must be performed as fast as possible to improve the
viability of their cells. Working under sterile conditions and
wearing examination gloves will decrease the chances of
contamination.
CRITICAL STEP In our experience, the skin is sufficiently
transparent before E12.5 to readily allow the identification
of the fluorescent progeny in most of the fluorescent
microscopes. Ultrafast genotyping protocols on the yolk
sacs of the individual embryos may be used as an alternative
(Lopez, 2012). Moreover, genotyping may be employed to
confirm the microscopic evaluation when the experiment is
initially attempted or if it is adapted tomurine lines different
from those detailed in this protocol.
(iii) With sterile forceps transfer the embryos presenting the
correct pattern of reporter gene expression in the myogenic
compartment in a clean dish containing supplemented
DMEM medium. Set also some non-fluorescent embryos
apart to use them as negative controls during the cytometer
isolation (Step 28).
CRITICAL STEP Be careful not to damage the body of the
embryo. The use of curved forceps should allow to gently
grabbing the embryos without piercing them. Alternatively
pinch portions of the embryo that will be subsequently
dissected away, such as the head (Step 15).
(B) Selection of Fluorescent Fetuses
(i) Prepare 6-well dishes and fill each well with 3ml of
supplementedDMEMmedium pre-warmed at 37◦C.With a
permanent marker label each well with a number. The total
number of wells should match the number of fetuses that
have been collected.
(ii) With forceps move each fetus in an individual well.
(iii) With fine forceps remove one of the forearms from each
fetus, dissect away the hand, remove the skin, and squeeze
it between two glass slides. Mark the slides with the number
of the corresponding fetuses.
CRITICAL STEP Be careful that the tissue between
the glass slides is not drying out, as it will increase
auto-fluorescence. We usually do not process more than 1-2
fetuses at the same time.
(iv) Place the glass slides under a fluorescence microscope and
observe with the appropriate filter to identify fluorescent
and non-fluorescent fetuses (Figure 3B).
CRITICAL STEP It is important to vigorously squeeze the
tissue between the two slides until it forms a thin layer. If
this step is not performed properly, the auto-fluorescence of
the tissue may become confounding. Auto-fluorescence is
particularly high in bones and in possibly remaining parts
of the skin. This could be misleading, in particular when
the protocol is attempted the first time. Before analyzing
the pattern of reporter gene expression, we suggest to
focus in the bright filed on the muscle mass, which is
easily identifiable by the presence of fibers at fetal stage
(Figure 3B). The direct comparison with non-fluorescent
fetuses may also be helpful (Figure 3B).
CRITICAL STEP Cre transgenes hold the potential to
induce efficient recombination of loxP sequences in the
germline (Schmidt-Supprian and Rajewsky, 2007). This
is particularly frequent in the female germline but may
also occur in the male (Rempe et al., 2006; Shi et al.,
2016). This is particularly relevant when mutant mice
that are used to mark myogenic progenitors, are double
compound mice in which an allele is driving the expression
of Cre-recombinase in the myogenic compartment (inducer
allele), and another is permanently expressing a reporter
gene upon Cre-dependent induction (reporter allele) (Abe
and Fujimori, 2013). We regularly employ three distinct
inducer lines to isolate myogenic progenitors (Table 1,
Supplementary Figure 1A). We usually cross males carrying
both the inducer and the reporter allele with WT females
(Step 1), and we regularly observe that, although a
large fraction of the progeny is correctly expressing the
reporter in the myogenic lineage, in a variable fraction
of the progeny the reporter is diffusely expressed outside
the myogenic compartment (Figure 4A, Supplementary
Figure 3). Importantly, this phenomenon occurs at different
rates in distinct inducer lines, being the Myf5-NNCre line
particularly affected (Figure 4B). This problem requires a
careful microscopic evaluation not only of the presence of
the fluorescent reporter but also of its pattern of expression.
Only embryos or fetuses specifically expressing the reporter
in the muscle lineage should be further processed to obtain
pure populations of myogenic progenitors.
Dissection of Embryos and Fetuses
-TIMING 5-10min per Embryo/Fetus
15. To optimize the purity and yield of myogenic progenitors,
and reduce the time of the procedure, it is important
to eliminate portions of embryos and fetuses in which
myogenic progenitors are scarce or absent. The modality of
dissection is different according to the developmental stage:
embryonic stage (from E10.5 to E12.5) (option A) or fetal
stage (from E13.5 to E17.5) (option B).
(A) Dissection of Embryos
(i) Prepare two 10-cm Petri dish with 10ml of sterile
supplemented DMEM medium. DMEM should be pre-
warmed at 37 ◦C.
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(ii) Dissect away the head (Figure 5A) and the internal organs
(Figure 5B) of each embryo.We use syringes with needles to
both hold and cut the embryos. To dissect we use the oblique
part of the needle as a blade.
CRITICAL STEP We suggest performing this step under
a stereomicroscope to guarantee a clean removal of the
internal organs without damaging the rest of the embryo.
This will facilitate the subsequent steps of the dissection.
(iii) With forceps transfer the embryos free from the internal
organs (Figure 5C) in a clean dish containing supplemented
DMEM medium, and position them with the ventral
portion facing down, in a “lion’s skin” position (Figure 5D).
This operation should be separately done both for
fluorescent and non-fluorescent (control) embryos.
CRITICAL STEP Be careful not to damage the body of the
embryo. The use of curved forceps should allow to gently
grabbing the embryos without piercing them.
(iv) Under a stereomicroscope cut the embryos lateral to the
neural tube and the chain of dorsal root ganglia. Use a
syringe needle to hold the embryo in position and with the
other cut on both side of the neural tube (Figures 5D,E)
in order to completely separate the neural tube with the
associated dorsal root ganglia from the rest of the body
(Figure 5F).
(v) Transfer the embryos free from the neural tube in a 15-ml
tube, containing the Digestion Solution (Figure 5G) and
shake vigorously by hand 2-3 times to disaggregate the
embryos in small pieces (Figure 5H).
CRITICAL STEP If the experimental design is requiring
that myogenic progenitors should be isolated from
specific portions of the embryos, such as the limb
buds, those portions should be further dissected at the
stereomicroscope, and only those should be transferred in
the Digestion Solution.
CRITICAL STEP The volume of Digestion Solution should
be sufficient to allow for effective physical dissociation of
the embryos during the enzymatic digestion. We usually fill
each15-ml tubes with ∼8ml of Digestion Solution with not
more than 6 embryos. Multiple tubes may be required if
multiple litters are processed at the same time. In general,
we do not suggest to process more than a dozen embryos, as
it will slow the isolation procedure affecting cell viability.
(B) Dissection of Fetuses
(i) Prepare two 10-cm Petri dish with 10ml of supplemented
DMEMmedium. DMEM should be pre-warmed at 37◦C.
(ii) Dissect away with forceps the head of the fetuses and
transfer the fetuses devoid of the head in a clean dish
containing supplemented DMEM medium (Figure 6A).
Fluorescent and non-fluorescent (control, Step 28) fetuses
should be pooled in different dishes.
(iii) Place each fetus with the dorsal portion facing down
and with forceps cut longitudinally the rib cage and the
abdomen to expose the internal organs (Figure 6B).
(iv) Eviscerate each fetus with curved forceps and transfer
it in a clean dish containing supplemented DMEM
medium (Figure 6C). The separation between fluorescent
and non-fluorescent (control) fetuses should be
maintained.
(v) Cut the extremities of the fore and hind limbs, leaving the
forearm and crus muscle intact. Position the fetus with
the ventral portion facing down, and with forceps remove
the skin at the stereomicroscope (Figure 6D). With curved
forceps, we grab the skin anteriorly, and by holding the
underneath tissues with other forceps, we pull it up caudally
until reaching the tail (Figure 6E).
CRITICAL STEP It is crucial to carefully remove the
extremities to obtain complete removal of the skin.
Whereas at E15.5 or later stages the skin can generally be
removed in a single piece, before E15.5 it consists in a thin
layer that may require a careful elimination of remaining
pieces at the stereomicroscope.
(vi) With curved forceps carefully eliminate the interscapular
fat pads from the skinned fetuses (Figures 6E,F).
CRITICAL STEP If the experimental design is requiring
that myogenic progenitors should be isolated from specific
portions of the fetuses, such as the limbs, only those
portions should be isolated from the rest of the body and
processed further.
(vii) Transfer the dissected fetal tissues in a 50-ml tube,
containing the Digestion Solution. Fluorescent and non-
fluorescent fetuses should be transferred in separate tubes.
CRITICAL STEPThe volume of Digestion Solution should
be sufficient to allow for effective physical dissociation of
the fetuses during the enzymatic digestion. We usually fill
each 50-ml tubes with ∼16ml of Digestion Solution with
not more than 6 fetuses. Multiple tubes may be required if
multiple litters are processed.
CRITICAL STEP The dissection must be performed as fast
as possible to improve the viability of the cells. Processing
more than six fetuses at the same time may slow the
isolation procedure affecting cell viability.
Isolation of Mononucleated Cells -TIMING
70–90 min
16. Seal the tubes well with Parafilm and position them in a
shaking water bath horizontally along the shaking path. Use
weights to keep the tubes completely submerged in water
(Figure 6G).
17. Incubate at 37◦C with agitation (∼70 r.p.m. on the
recommended model of shaking water bath) for 15min.
18. Remove the Parafilm, place the tubes on a rack and let the
digesting embryos or fetuses accumulate on the bottom of
the tube for∼1min.
CRITICAL STEP This and the fallowing steps should be
performed in a sterile hood if cells will be cultured.
19. With a 5-ml pipette gently transfer the supernatant
containing the disaggregated cells in a clean labeled 15-ml
tube and place it in ice.
CRITICAL STEP Be careful to not aspirate the digesting
embryos or fetuses. In particular, embryos form an aggregate
that can easily be disturbed. To avoid it, control the
Frontiers in Physiology | www.frontiersin.org 13 April 2018 | Volume 9 | Article 352
Kheir et al. Isolation of Developmental Muscle Progenitors
aspiration strength, aspirate from the surface of the
supernatant, and leave∼1ml of supernatant in the tube.
20. Add new digestion solution to the tube containing the
embryos (8ml) or fetuses (16ml), seal the tubes with
Parafilm, shake vigorously 2–3 times by hand, and incubate
as previously described for additional 15min.
21. In the meanwhile, centrifuge the aspirated supernatant in a
swinging-bucket rotor at 500 g for 5min at 4◦C. Carefully
discard the solution without disturbing the cellular pellet.
Resuspend the cells in∼1ml of ice-cold Sorting Solution and
place in ice.
22. Repeat Steps 18–21 until digesting pieces of tissue are not
visible anymore in the case of the embryonic preparations,
or until cartilage and bones are completely devoid of muscle
in the case of fetal preparations. Whereas the cell pellet
is initially resuspended in fresh Sorting Solution (Step 21),
at the end of the subsequent cycles of digestion resuspend
the cell pellet with the cell suspension obtained during the
previous cycles. In this way, at the end of the digestion, the
cell fractions derived from the digestion of a single pool of
embryos/fetuses will end up in a single tube.
CRITICAL STEP In our conditions, 3 and 4 cycles are
usually sufficient to digest respectively E11.5 embryos and
E15.5 fetuses. Be careful to not terminate the digestion when
small undigested pieces of the embryo are still present, and to
not over-digest the fetal samples, as in both cases the fraction
of myogenic progenitors will be reduced.
CRITICAL STEP At the fetal stage, the presence of
erythrocytes may render the quantification of the cells
(Step 26) and the FACS-isolation (Steps 27–32) problematic.
To remove the majority of the erythrocytes we suggest
to centrifuge fetal samples as described in Step 21 and
resuspend the cellular pellet in Erythrocyte Lysis Buffer.
After 2min of incubation at room temperature, centrifuge
the samples and resuspend with∼1ml of Sorting Solution.
23. Transfer the cellular suspension to the strain cap attached to
a 5-ml FACS tube. Pipette up and down gently to facilitate
flow-through.
24. Rinse the tube that was containing the resuspended cells with
another 1ml of Sorting Solution, and transfer it to the same
strainer cap.
CRITICAL STEP If multiple embryos/fetuses are processed
at the same time, the strainer can be clogged. Carefully
recover all traces of liquid from the clogged strainer (both
outside and underside) before changing to a new one.
25. Remove the strainer cap and collect with a 20–200-µl pipette
any remaining liquid on the underside of the strainer. Close
the tube with a plastic cap and maintain in ice.
Cell Sorting -TIMING ∼20min per
Embryo/Fetus
26. Mix the samples by gently pipetting or vortexing, estimate
the concentration of the filtered cell suspension, and adjust
the concentration to ∼2 × 106 cells per ml with ice-cold
Sorting Solution. Split into multiple FACS tubes if the final
volume is more than 4ml.
CRITICAL STEP It is best to move immediately to cell
sorting for the highest yield and viability.
27. Set up the cell sorter according to the manufacturer’s
guidelines with a 100-µm nozzle.
28. Run the non-fluorescent cellular suspension to properly set
the voltages. Ensure that the cell population is presenting low
background fluorescence and is appropriately positioned in
the SSC and FSC-A plot (Figure 7A).
29. Create a gate on the bidimensional SSC and FSC-A plot to
exclude debris (P1, Figure 7).
30. Create a gate on the FSC-H and FSC-A plot to select for
intact single cells (P2, Figure 7).
CRITICAL STEP In our hands, this gating strategy is
efficiently excluding doublets of cells, dead cells, and
fragmented fibers (particularly present at fetal stage) that
present an irregular shape.
31. Generate the gate to identify the fluorescently labeled cells
(P3, Figure 7, Supplementary Figure 4).
32. Sort the fluorescent progenitors in a 5-ml round bottom
collection tube containing 2ml of ice-cold Collecting Media
at a flow rate between 1,000 and 3,000 events per second.
CRITICAL STEP We suggest to rinse the walls of the
collection tube with Collecting Media to facilitate the flow
to the bottom of the tube of droplets containing the sorted
cells.
CRITICAL STEP To reduce the risk of bacterial
contamination we suggest to run 70% (vol/vol) ethanol
through the fluidic system before sorting.
Processing of Sorted Cells -TIMING
Variable
33. Sorted cells can be immediately frozen for RNA isolation
(option A), for protein purification (option B), or can be
plated on culture dishes or slides to follow their spontaneous
differentiation (option C).
(A) Freezing myogenic progenitors for
RNA isolation -TIMING 20 min
(i) Transfer the content of the collection tube in a 15-ml
conical tube and centrifuge in a swinging-bucket rotor
at 500 g for 10min at 4◦C. With a 100–1,000-µl pipette
gently remove the media down to ∼1ml, resuspend the
cellular pellet and transfer it to a 1.5-ml microcentrifuge
tube.
CRITICAL STEP To avoid RNA degradation we suggest
to use RNAse-free tubes and tips with filters.
(ii) Centrifuge the tubes in a fixed angle rotor at 2,500 g for
5min at 4◦C and aspirate the supernatant completely
with a 20–200-µl pipette.
CRITICAL STEPTo avoid the loss of sorted cells control
the aspiration strength and aspirate from the surface of
the supernatant.
(iii) Snap-freeze the cell pellet in liquid nitrogen or by placing
the tube at −80◦C. Samples can be stored for several
months at−80◦C.
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CRITICAL STEP It is crucial to immediately
snap-freeze the pellet to avoid RNA degradation.
Dissociation in dedicated commercial buffers containing
β-mercaptoethanol (i.e. RLT Buffer, Qiagen) is an
alternative we successfully used.
(B) Freezing myogenic progenitors for
protein purification -TIMING 25 min
(i) Process cells as described in Steps 33A (i) and (ii).
(ii) Wash the pellet by filling the tube with 1ml of PBS,
Centrifuge the tubes in a fixed angle rotor at 2,500 g for
5min at 4◦C and aspirate the supernatant completely with a
20–200-µl pipette.
(iii) Snap-freeze the cell pellet in liquid nitrogen. Samples can be
stored for several months in liquid nitrogen or at−80◦C.
CRITICAL STEP It is crucial to proceed immediately with the
freezing of the samples to avoid degradation.
(C) In vitro culturing -TIMING 30–35min to
set up
(i) Prepare coated plastic wells or glass chambers for cell
seeding.
CRITICAL STEP Collagen-coated plastic wells and ECM-
coated glass chambers slides can be used for culturing.
Nevertheless, we suggest to use ECM-coated glass chambers
for microscopic analysis after immunofluorescence.
(ii) Plate cells in Plating Medium and place them in an
incubator at 37◦C with 5% CO2. We usually plate ∼15,000
cells in 300µl of PlatingMedium per well in 8-well chamber
slides or ∼10,000 cells in 200 µl of Plating Medium per
well in 96-well plates. After plating, cells adhere to the well
surface within hours.
CRITICAL STEPWe usually plate cells in Plating Medium,
but we successfully used also Opti-MEM (Thermofisher
Scientific) supplemented with 20% (vol/vol) FBS, 20mM
HEPES, and 5 ng/ml bFGF (Peprotech) to delay terminal
differentiation (Boutet et al., 2010).
(iii) Replace half of the medium every day with fresh Plating
Medium. Cells (in particular the embryonic population)
become elongated and align with neighboring cells within
1–2 days. Terminal differentiation continues, and by
the end of day 3, most of the cells have fused. The
degree of fusion and the size of mature myotubes are
dependent on cell density and the developmental stage
of the myogenic progenitors. Progenitors isolated at
embryonic stage form small myotubes containing few
nuclei, whereas progenitors purified from fetal muscles
form large myotubes containing many nuclei. If cultures
are protracted beyond day 3, embryonic progenitors will
progressively detach from the culture surface and after day
6 only a few elongated cells are adhering to the well. Most
fetal progenitors will continue to fuse without detaching
until day 6.
CRITICAL STEP Use a pipette to remove half of the medium
and to slowly add the fresh medium. We usually use a 20–200-µl
pipette with filtered sterile tips when we are using 8-well glass
chambers slides or 96-well plates. Be careful to not disturb the
adherent layer of cells.
TIMING
Collection of the fluorescent progeny
Steps 1–2, setting up timed pregnant mice: 5min per mouse
Steps 3–13, collection of embryos and fetuses: 20min per
pregnant female
Step 14, identification of fluorescent progeny: 20min per
pregnant female.
Dissection and enzymatic digestion of embryos or fetuses
Step 15, dissection of embryos and fetuses: 5–10min per
embryo/fetus
Steps 16–25, enzymatic isolation of mononucleated cells: 70–
90 min.
FACS isolation of progenitors and preparation for
molecular analysis
Steps 26–32, cell sorting: 20min per embryo/fetus
Step 33A, freezingmyogenic progenitors for RNA isolation: 20
min
Step 33B, freezing myogenic progenitors for protein
purification: 25 min
Step 33C, in vitro culturing: 30–35min to set up.
ANTICIPATED RESULTS
With this protocol we usually obtain 10,000–100,000 myogenic
progenitors per conceptus, depending on the developmental
stage, and the mouse strain used for the isolation. For example
∼12,000, ∼40,000, and ∼100,000 cells are obtained respectively
from each E11.5 Myf5GFP−P embryo, E15.5 Myf5GFP−P fetus or
E11.5 Pax3GFP embryo. Obviously the number of isolated cells
decreases if cells are obtained only from restricted portions of the
embryos (for example the limbs). Isolated cells are consistently
≥95% pure when reanalyzed after the sorting for the expression
of the reporter gene used for FACS-purification (Supplementary
Figure 5), and are highly myogenic (up to 99% when analyzed
for myogenic markers 12 h after sorting; Figures 8A,B; Biressi
et al., 2007b). The embryonic or fetal lineage of the myogenic
progenitors purified with this protocol at different developmental
stages can be verified by the quantification of stage-specific
markers, such as Arx and Pax3 for embryonic progenitors or Nfix,
PKCθ and Itga7 for fetal progenitors (Biressi et al., 2007b, 2008;
Messina et al., 2010).
NOTES
Troubleshooting advice can be found in Table 2.
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